Novel barbituric acid derivatives, uracil-pyridinium salts and polycondensed oxopyrimidines

Heterocycles

Volumn 43, Issue 10, 1996, Pages 2153-2167

  Schmidt, Andreas ^a   Hetzheim, Annemarie ^a   Albrecht, Dirk ^a  

^a UNIVERSITY OF GREIFSWALD   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0343854396     PISSN: 03855414     EISSN: None     Source Type: Journal    
DOI: 10.3987/com-96-7529     Document Type: Article

References (29)

1. D. J. Brown, A. R. Katritzky, and C. W. Rees, 'Comprehensive Heterocyclic Chemistry,' Vol. 3, Pergamon Press, Oxford, 1984, pp. 57-155.
2. E. Fischer and J. R. von Mering, Thr. Ggw. 1903, 44, 97.
3. A. Andreani, M. Rambaldi, A. Locatelli, A. Leoni, R. Bossa, M. Chiericozzi, I. Galatulas, and G. Salvatore, Eur. J. Med. Chem., 1993, 28, 825; J. T. Bojarski, J. L. Mokrosz, H. J. Barton, and M. H. Paluchowska, Adv. Heterocycl Chem., 1985, 38, 229.
4. A. Andreani, M. Rambaldi, A. Locatelli, A. Leoni, R. Bossa, M. Chiericozzi, I. Galatulas, and G. Salvatore, Eur. J. Med. Chem., 1993, 28, 825; J. T. Bojarski, J. L. Mokrosz, H. J. Barton, and M. H. Paluchowska, Adv. Heterocycl Chem., 1985, 38, 229.
5. see: lit. [3b] and literature cited therein and e.g. F. Fujioka, T. Koike, N. Yamada, and E. Kimura, Heterocycles, 1996, 42, 775; M. Rabbani, E. J. Wright, and H. J. Little, Pharmacol., Biochem. Behav., 1995, 50, 9; H. Tanigawa, H. Onedura, and A. Maekawa, J. Toxicol. Sci., 1995, 20, 55; S. Korkmaz, S. Ljungblad, and G. Wahlstroem, Brain Res., 1995, 676, 371; P. Germann, I. Laher, T. Poseno, and J. A. Bevan, Can. J. Physiol. Pharmacol., 1994, 72, 963; L. C. Daniell, Pharmacology, 1994, 49, 296.
6. see: lit. [3b] and literature cited therein and e.g. F. Fujioka, T. Koike, N. Yamada, and E. Kimura, Heterocycles, 1996, 42, 775; M. Rabbani, E. J. Wright, and H. J. Little, Pharmacol., Biochem. Behav., 1995, 50, 9; H. Tanigawa, H. Onedura, and A. Maekawa, J. Toxicol. Sci., 1995, 20, 55; S. Korkmaz, S. Ljungblad, and G. Wahlstroem, Brain Res., 1995, 676, 371; P. Germann, I. Laher, T. Poseno, and J. A. Bevan, Can. J. Physiol. Pharmacol., 1994, 72, 963; L. C. Daniell, Pharmacology, 1994, 49, 296.
7. see: lit. [3b] and literature cited therein and e.g. F. Fujioka, T. Koike, N. Yamada, and E. Kimura, Heterocycles, 1996, 42, 775; M. Rabbani, E. J. Wright, and H. J. Little, Pharmacol., Biochem. Behav., 1995, 50, 9; H. Tanigawa, H. Onedura, and A. Maekawa, J. Toxicol. Sci., 1995, 20, 55; S. Korkmaz, S. Ljungblad, and G. Wahlstroem, Brain Res., 1995, 676, 371; P. Germann, I. Laher, T. Poseno, and J. A. Bevan, Can. J. Physiol. Pharmacol., 1994, 72, 963; L. C. Daniell, Pharmacology, 1994, 49, 296.
8. see: lit. [3b] and literature cited therein and e.g. F. Fujioka, T. Koike, N. Yamada, and E. Kimura, Heterocycles, 1996, 42, 775; M. Rabbani, E. J. Wright, and H. J. Little, Pharmacol., Biochem. Behav., 1995, 50, 9; H. Tanigawa, H. Onedura, and A. Maekawa, J. Toxicol. Sci., 1995, 20, 55; S. Korkmaz, S. Ljungblad, and G. Wahlstroem, Brain Res., 1995, 676, 371; P. Germann, I. Laher, T. Poseno, and J. A. Bevan, Can. J. Physiol. Pharmacol., 1994, 72, 963; L. C. Daniell, Pharmacology, 1994, 49, 296.
9. see: lit. [3b] and literature cited therein and e.g. F. Fujioka, T. Koike, N. Yamada, and E. Kimura, Heterocycles, 1996, 42, 775; M. Rabbani, E. J. Wright, and H. J. Little, Pharmacol., Biochem. Behav., 1995, 50, 9; H. Tanigawa, H. Onedura, and A. Maekawa, J. Toxicol. Sci., 1995, 20, 55; S. Korkmaz, S. Ljungblad, and G. Wahlstroem, Brain Res., 1995, 676, 371; P. Germann, I. Laher, T. Poseno, and J. A. Bevan, Can. J. Physiol. Pharmacol., 1994, 72, 963; L. C. Daniell, Pharmacology, 1994, 49, 296.
10. see: lit. [3b] and literature cited therein and e.g. F. Fujioka, T. Koike, N. Yamada, and E. Kimura, Heterocycles, 1996, 42, 775; M. Rabbani, E. J. Wright, and H. J. Little, Pharmacol., Biochem. Behav., 1995, 50, 9; H. Tanigawa, H. Onedura, and A. Maekawa, J. Toxicol. Sci., 1995, 20, 55; S. Korkmaz, S. Ljungblad, and G. Wahlstroem, Brain Res., 1995, 676, 371; P. Germann, I. Laher, T. Poseno, and J. A. Bevan, Can. J. Physiol. Pharmacol., 1994, 72, 963; L. C. Daniell, Pharmacology, 1994, 49, 296.
11. J. A. Bikker, J. Kubanek, and D. F. Weaver, Epilepsia, 1994, 35, 411; P. R. Andrews, L. C. Mark, D. A. Winkler, and G. P. Jones, J. Med. Chem., 1983, 26, 1223.
12. J. A. Bikker, J. Kubanek, and D. F. Weaver, Epilepsia, 1994, 35, 411; P. R. Andrews, L. C. Mark, D. A. Winkler, and G. P. Jones, J. Med. Chem., 1983, 26, 1223.
13. H. Wamhoff, J. Dzenis, and K. Hirota, Adv. Heterocycl. Chem., 1992, 55, 134.
14. K. Klemm, W. Prüsse, and U. Krüger, Arzneim.-Forsch., 1977, 27, 1895.
15. G. D. Daves Jr., R. K. Robins, and C. C. Cheng, J. Org. Chem., 1961, 26, 5256.
16. W. Pfleiderer and K.-H. Schündehütte, Chem. Ber., 1958, 612, 158.
17. T. Itoh, H. Ogura, N. Kawahara, and K. A. Watanabe, Heterocycles, 1980, 14, 159.
18. C. Reichardt and E. Harbusch-Görnert, Liebigs Ann. Chem., 1983, 721; C. Reichardt, 'Solvents and Solvent Effects in Organic Chemistry,' 2nd ed., VCH Verlagsgesellschaft mbH, Weinheim, 1990.
19. C. Reichardt and E. Harbusch-Görnert, Liebigs Ann. Chem., 1983, 721; C. Reichardt, 'Solvents and Solvent Effects in Organic Chemistry,' 2nd ed., VCH Verlagsgesellschaft mbH, Weinheim, 1990.
20. K. P. Sagarik and B. M. Rode, Inorg. Chim. Acta 1983, 76, L209.
21. M. Goodgame and D. A. Jakubovic, Coordination Chem. Rev., 1987, 79, 97.
22. For a related LFE Relationship, see: I. H. Pitman, M. J. Cho, and G. S. Rork, J. Am. Chem. Soc., 1974, 96, 1840; for stable Meisenheimer adducts, see e. g. G. Illuminati and F. Stenel, Adv. Heterocycl. Chem., 1983, 34, 305; for relative reactivities of pyrimidines, see: M. Maltese, J. Org. Chem., 1995, 60, 2436.
23. For a related LFE Relationship, see: I. H. Pitman, M. J. Cho, and G. S. Rork, J. Am. Chem. Soc., 1974, 96, 1840; for stable Meisenheimer adducts, see e. g. G. Illuminati and F. Stenel, Adv. Heterocycl. Chem., 1983, 34, 305; for relative reactivities of pyrimidines, see: M. Maltese, J. Org. Chem., 1995, 60, 2436.
24. For a related LFE Relationship, see: I. H. Pitman, M. J. Cho, and G. S. Rork, J. Am. Chem. Soc., 1974, 96, 1840; for stable Meisenheimer adducts, see e. g. G. Illuminati and F. Stenel, Adv. Heterocycl. Chem., 1983, 34, 305; for relative reactivities of pyrimidines, see: M. Maltese, J. Org. Chem., 1995, 60, 2436.
25. Y. Marcus, J. Sol. Chem., 1984, 13, 599.
26. F. Yoneda, M. Ono, K. Kira, H. Tanaka, Y. Sakuma, and A. Koshiro, Chem. Lett., 1980, 817.
27. A. E. Tschitschibabin and I. L. Knunjanz, Ber., 1931, 64, 2839; G. R. Clemo and G. A. Swan, J. Chem. Soc., 1945, 603; M. Kondo, Bull. Chem. Soc. Jpn., 1976, 49, 1443.
28. A. E. Tschitschibabin and I. L. Knunjanz, Ber., 1931, 64, 2839; G. R. Clemo and G. A. Swan, J. Chem. Soc., 1945, 603; M. Kondo, Bull. Chem. Soc. Jpn., 1976, 49, 1443.
29. A. E. Tschitschibabin and I. L. Knunjanz, Ber., 1931, 64, 2839; G. R. Clemo and G. A. Swan, J. Chem. Soc., 1945, 603; M. Kondo, Bull. Chem. Soc. Jpn., 1976, 49, 1443.